PHARMACOKINETICS
How Long Ipamorelin Stays in Your System: Half-Life
About two hours to clear half, a single GH pulse near forty minutes, and a urine-detection window that outlasts both — the kinetics in full.
The short version
How long does ipamorelin stay in your system? In healthy human volunteers, the terminal half-life — the time for blood levels to fall by half once clearance is underway — was about 2 hours after an intravenous dose [2]. A rough rule of thumb in pharmacology is that a drug is mostly gone after four to five half-lives, which for Ipamorelin would put near-complete clearance in roughly 8 to 10 hours. The active effect is even shorter: the growth-hormone pulse it triggers peaks about 40 minutes after dosing and then fades [2]. One important wrinkle — "out of your bloodstream" and "undetectable in a drug test" are not the same thing. Anti-doping laboratories detect Ipamorelin and its breakdown products in urine well after the peptide itself has cleared the blood [11], which is why athletes are tested on metabolites, not the parent peptide.
The human pharmacokinetic numbers
The defining dataset comes from a population PK/PD study in healthy male volunteers given five single intravenous infusions spanning 4.21 to 140.45 nmol/kg over 15 minutes [2]. Three numbers summarize it: a terminal half-life of approximately 2 hours, a clearance of 0.078 L/h/kg, and a steady-state volume of distribution of 0.22 L/kg [2]. The kinetics were dose-proportional — exposure scaled linearly with dose across the whole range, with no surprises at the top end. That linearity matters because it means the compound's behavior is predictable: there is no evidence of saturation or accumulation within the studied single-dose range. This is one of the only human Ipamorelin datasets in existence, which is why nearly every credible half-life figure traces back to it.
The single GH pulse: about forty minutes
The pharmacodynamic half of the same study is just as clean. Rather than a broad, sustained rise, Ipamorelin produced a single discrete growth-hormone pulse that peaked at roughly 0.67 hours — about 40 minutes — after dosing [2]. This is the signature that makes the compound pharmacologically interesting: it mimics the body's own pulsatile GH rhythm, a brief spike followed by a return to baseline, rather than the flat elevation that older or cruder approaches produce. The pulse shape is downstream of the receptor mechanism — GHS-R1a activation drives a calcium-triggered GH release [1] — and it resolves on a timescale consistent with the ~2-hour clearance of the peptide that triggered it.
What the animal kinetics add
Rodent data fills in the metabolic-stability picture. In male rats, Ipamorelin showed roughly 5-fold lower systemic plasma clearance than GHRP-6, with 60-80% of the administered dose recovered intact in bile and urine — evidence of moderate metabolic stability, helped by the non-natural residues that resist enzymatic breakdown [10]. The same study measured an intranasal bioavailability of about 20%, meaningful but modest [10]. The greater stability versus GHRP-6 is consistent across the rat and human work and is part of why Ipamorelin was considered a more refined secretagogue than the earlier GHRPs. None of this changes the human half-life figure — it explains the molecular reasons behind it.
Detection outlasts clearance
For anyone thinking about Ipamorelin's status in sport, the detection window is the number that matters, and it is longer than the blood half-life. A comprehensive metabolism study identified at least three urinary metabolites of Ipamorelin, formed by exopeptidase, amidase, and endopeptidase activity, characterized by UHPLC-Orbitrap mass spectrometry [8]. High-throughput LC-MS/MS and solid-phase-extraction methods detect Ipamorelin and its metabolites in human and equine urine [9], and metabolite work after nasal administration underpins the accredited detection assays [11]. Ipamorelin is prohibited in sport at all times under WADA category S2, and these methods make that prohibition enforceable [11]. The peptide clears the blood in hours; the metabolite evidence in urine persists longer.
Why the half-life is the whole design
The two-hour half-life is not a footnote — it is the point of the molecule. A short, clean half-life paired with a single 40-minute GH pulse is exactly the profile a pulsatile-GH approach wants: deliver a transient signal, then get out of the way so the axis can reset [2]. It is why the studied regimens lean on repeated short exposures rather than continuous dosing (see the dosage page), and it sets up the companion question of onset — covered on how long does it take for ipamorelin to work. Read together, the half-life and onset data describe a compound engineered around timing as much as potency.